Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case report

Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case report

Metastatic uveal melanoma (UM) is a rare form of melanoma differing from cutaneous melanoma by etiology, prognosis, driver mutations, pattern of metastases and poor response rate to immune checkpoint inhibitors (ICI). Recently, a bispecific gp100 peptide-HLA-directed CD3 T cell engager, tebentafusp,...

Full description

Bibliographic Details
Main Authors: Selina Reiter, Christopher Schroeder, Julian Broche, Tobias Sinnberg, Irina Bonzheim, Daniela Süsskind, Lukas Flatz, Andrea Forschner
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Oncology
Subjects:
tebentafusp
immune checkpoint inhibitors
uveal melanoma
bi-specific therapy
ctDNA
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1167791/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1167791/full

Similar Items